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In Brief
Using a panel of techniques, including a
ribonucleoproteomic approach based on
tagged protein affinity purification
combined with next-generation
sequencing, Chazal et al. show that the
cytoplasmic sensor RIG-I plays a key role
in cellular defense against Dengue and
Zika viruses.
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The flavivirus genus comprises major human patho-
gens, such as Dengue (DENV) and Zika (ZIKV)
viruses. RIG-I and MDA5 are key cytoplasmic path-
ogen recognition receptors that are implicated in
detecting viral RNAs. Here, we show that RNAs that
co-purified with RIG-I during DENV infection are im-
muno-stimulatory, whereas RNAs bound to MDA5
are not. An affinity purification method combined
with next-generation sequencing (NGS) revealed
that the 50 region of the DENV genome is recognized
by RIG-I. No DENV RNA was bound to MDA5.
In vitro production of fragments of the DENV genome
confirmed the NGS data and revealed that the 50 end
of the genome, when bearing 50-triphosphates, is the
RIG-I ligand. The 50 region of the ZIKV genome is also
a RIG-I agonist. We propose that RIG-I binds to the
highly structured and conserved 50 region of flavivi-
rus nascent transcripts before capping and that this
mechanism leads to interferon secretion by infected
cells.
INTRODUCTION
The flavivirus genus comprises major human pathogens, such
as Dengue virus (DENV), West Nile virus (WNV), and Zika virus
(ZIKV). DENV is the most prevalent and rapidly spreading arbo-
viral disease of humans (Guzman et al., 2016). An estimated
400 million people are affected every year, with symptomatic
cases ranging from mild fever to life-threatening dengue hemor-
rhagic fever and dengue shock syndrome. Four DENV serotypes
(DENV-1 to DENV-4), which co-circulate in tropical and subtrop-
ical regions, differ from one another by at least 25%at the amino-
acid level. ZIKV was first isolated in Uganda in 1947. It emerged
in Micronesia in 2007, followed by larger epidemics in the Pacific
Islands and in Central and South America, with more than a
million suspected cases in 2016 (Enfissi et al., 2016). The first se-
vere neurological complications and non-vector-borne transmis-
sion of the virus were reported at that time (Baud et al., 2017).
The flavivirus genome is a single-stranded positive-sense RNA
molecule of around 10.7 kb, encoding a polyprotein precursor320 Cell Reports 24, 320–328, July 10, 2018 ª 2018 The Author(s).
This is an open access article under the CC BY-NC-ND license (http://that is processed by the viral protease NS3 to give rise
to 7 non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A,
NS4B, and NS5) and 3 structural proteins (capsid, membrane
precursor, and envelope) (Fernandez-Garcia et al., 2009). The
coding region of the genome is flanked by 50 and 30 UTRs that
contain conserved sequences and secondary structures neces-
sary for RNA replication, translation, and packaging (Villordo
et al., 2016). Flavivirus replication occurs on the cytoplasmic
side of endoplasmic reticulum (ER)-derived pocket-like invagi-
nations (Welsch et al., 2009).
The innate immune system has evolved to rapidly control RNA
virus replication and limit its spread via detection of the genome
by pattern recognition receptors. Viral replicative intermediates
that accumulate in the cytosol are sensed by RIG-I-like receptors
(RLRs) (Brennan andBowie, 2010). To date, three RLRmembers,
which are expressed inmost tissues, have been identified: RIG-I,
MDA5, and LGP2 (Errett andGale, 2015). They share a number of
structural similarities, including their organization into distinct do-
mains: a central DExD/H box RNA helicase domain and a C-ter-
minal repressor domain. In addition, RIG-I and MDA5 possess
two N-terminal caspase activation and recruitment domains
(CARDs). LGP2 lacks the CARD domain and is believed to func-
tion as a negative and a positive regulator of RIG-I and MDA5
signaling, respectively (Moresco and Beutler, 2010). Upon RNA
binding, RIG-I and MDA5 expose their CARD domains, and this
facilitates their interaction with the adaptor protein MAVS and
leads to the activation of IRF3 and IRF7 transcription factors,
which trigger the rapid expression of type I interferon a and b
(IFNa and IFNb). Secreted IFNa/bwill then bind to their receptors
and activate the canonical JAK/STAT pathway in both infected
and surrounding cells. Subsequently, the expression of up to
approximately 400 IFN-stimulated genes (ISGs) displaying anti-
viral properties is induced (Schoggins et al., 2011), effectively es-
tablishing the antiviral state. To trigger antiviral immunity, RIG-I
and MDA5 interact with particular signatures on viral RNA. Rela-
tively short double-stranded RNAs (dsRNAs) with a 50-triphos-
phate (3P) end are ideal RIG-I ligands (Kell and Gale, 2015).
RIG-I can also detect poly(U/UC)-rich motifs found in the
30 UTRof hepatitis C genome (Schnell et al., 2012).MDA5 ligands
are much less characterized and are presumed to be long
dsRNAs, with no requirement for 503P (Schlee, 2013).
In MAVS/mice, type I IFN production is delayed in lymphoid
tissues until 18 hr post-DENV-2 infection, revealing that RIG-I-
and/or MDA5-mediated sensing acts as a first line of innatecreativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Viral Replication and Immune Response in MDDCs upon DENV Infection
MDDCs were infected with DENV-2 Malaysia, DENV-4 Dominica, or DENV-2 16681 at an MOI of 1.
(A) The relative amounts of cell-associated viral RNA were determined by qPCR analysis at 15 min, 8 hr, and 24 hr post-infection. Amounts of viral RNA are
expressed as genome equivalents (GEs) per microgram of total cellular RNA.
(B) The relative amounts of IFNB and ISG56 mRNAs were determined by qPCR analysis at 8 and 24 hr post-infection.
(C) Cell culture medium was analyzed by ELISA to determine the amount of IFN-b secreted 24 hr post-infection. ni, noninfected.
Data are means ± SD of technical duplicates representative of 2 independent experiments.defense against infection in this animal model (Perry et al., 2009).
Consistently, both sensors are involved in DENV-2 recognition in
mouse embryonic fibroblasts (Loo et al., 2008). However, the
exact viral nucleic acid sequence that is engaged by either
RIG-I or MDA5 during flavivirus replication remains unknown.
To identify the viral RNA signature on RLRs during viral infec-
tions, we have developed a riboproteomic approach based on
tagged protein affinity purification combined with next-genera-
tion sequencing (NGS) (Sanchez David et al., 2016). We showed,
for example, that upon infection with the measles virus, RIG-I
recognized defective interfering viral genomes, whereas MDA5
specifically bound the nucleoprotein-coding region of the
genome (Sanchez David et al., 2016). Here, we used this
approach to determine which viral RNA motifs are recognized
by RIG-I and MDA5 during infection with two low-passage clin-
ical isolates of DENV-2 and DENV-4.
RESULTS
Viral Replication and Immune Response in MDDCs upon
DENV Infection
We first evaluated the ability of human monocyte-derived den-
dritic cells (MDDCs), which are target cells for DENV (Wu et al.,
2000), to induce IFN response upon infection with low-passage
clinical isolates of DENV-2 (Malaysia) and DENV-4 (Dominica)
or, as a comparison, with the laboratory-adapted DENV-2 strain
16681. Assessment of viral replication by real-time qPCR re-
vealed that the Dominica DENV-4 isolate produced more viral
RNA than the two DENV-2 strains at 8 and 24 hr post-infection
in MDDCs purified from two donors (Figure 1A). At 8 hr post-
infection, IFNB and ISG56 mRNAs were more abundant in
MDDCs infected with the clinical isolates than with the adapted
DENV-2 16681 strain (Figure 1B). Consistently, IFN-b protein
was secreted by MDDCs infected with the clinical isolates for
24 hr, whereas MDDCs infected with DENV-2 16681 secreted
as little IFN-b as non-stimulated cells did (Figure 1C). These
data are in agreement with a study showing that no IFN-a was
produced by MDDCs upon DENV-2 16681 infection (Aguirre
et al., 2017). One can envisage that laboratory-adapted strains
such as DENV-2 16681 have evolved efficient mechanisms tocounteract IFN response along cell passages. DENV-2 and
DENV-4 low-passage isolates were, therefore, chosen to further
study RLRs stimulation in infected human cells.
RIG-I Is the Main Sensor for DENV-2 and DENV-4 in
HEK293 Cells
To determine the implication of RIG-I and MDA5 in DENV
sensing, we took advantage of STING-37 cells, which are
HEK293 cells stably expressing luciferase under the control of
the IFN-stimulated response element (ISRE) promoter (Lucas-
Hourani et al., 2013) and in which the expression of RIG-I or
MDA5 is reduced by stable expression of short hairpin RNA
(shRNA) (Sanchez David et al., 2016). Stable shRNA silencing
reduced the level of RIG-I and MDA5 mRNAs by 70% and
65%, respectively, when compared to cells expressing scram-
bled control shRNA (Figure 2A). Western blot analysis showed
that the abundance of RIG-I was reduced by 50% in sh-RIG-I
cells compared to short hairpin RNA control (sh-control) cells
(Figure S1). MDA5 was 60% less abundant in sh-MDA5
cells than in sh-control cells. Importantly, in non-stimulated cells,
reduced abundance of one RLR did not affect the expression of
the other (Figure S1). As expected for ISGs, RIG-I and MDA5
abundance was increased when cells were treated with low-mo-
lecular-weight (LMW) poly(I:C), which contains 0.2- to 1-kb-long
synthetic dsRNAs that are recognized by both RIG-I and MDA5
(Kato et al., 2008). In these stimulated cells, abundance of
RIG-I and MDA5 was reduced by 70% and 60%, respec-
tively, as compared to sh-control cells (Figure S1). IRF3 phos-
phorylation was reduced in both sh-RIG-I and sh-MDA5 cells
upon LMW poly(I:C) stimulation as compared to control cells,
validating further our silencing approach.
Viral replication 24 hr post-infection was not affected by
reduced expression of RIG-I or MDA5 (Figure 2B). This is likely
because IFN response is low at this time point (see Figures 3E
and 3F). Control experiments were performed by transfecting
STING-37-shRLR cells with 503P, a RIG-I ligand; with LMW
poly(I:C), which contains both RIG-I and MDA5 ligands (Kato
et al., 2008); or with RNAs extracted from HEK293 cells infected
with mengovirus, a member of the Picornaviridae family, which is
sensed exclusively byMDA5 (Feng et al., 2012; Gitlin et al., 2006;Cell Reports 24, 320–328, July 10, 2018 321
Figure 2. RIG-I Is the Main Sensor for DENV-2 and DENV-4 in HEK293 Cells
(A) The relative abundances of RIG-I and MDA5 mRNAs were determined by qPCR analysis in STING-37 cells expressing control sh-RNA or RIG-I- or MDA5-
specific sh-RNAs. Results are presented as percentages of the amounts of the indicated mRNAs detected in sh-control cells, which were set at 100%.
(B) The indicated shRNA-expressing STING-37 cells were infected with DENV-2 or DENV-4 for 24 hr. Amounts of cell-associated viral RNA were measured by
qPCR analysis and were expressed as genome equivalents (GEs) per microgram of total cellular RNA.
(C andD) The indicated shRNA-expressing STING-37 cells were transfectedwith LMWpoly(I:C), 503PRNA, or total RNA extracted frommengovirus-infected cells
(Mengo). Alternatively, cells were infected with DENV-2 and DENV-4. After 6 hr of transfection or 24 hr of infection, mRNA levels of (C) IFNB or (D) ISG56 were
determined by qPCR analysis. Results are represented as fold of RNA levels compared to mock cells and expressed as percentage relative to shRNA control
cells, which were set at 100%.
(E) The indicated shRNA-expressing STING-37 cells were transfected or infected as in (C). ISRE activation was assessed by luciferase assays following 6 hr of
transfection or 24 hr of infection. Results are represented as fold increase of luciferase expression compared to mock cells, and expressed as percentage relative
to sh-RNA control cells, which were set at 100%.
(F) HEK293 ST-RLR cells were infected with DENV-2 and DENV-4 at an MOI of 0.5 for 24 hr. To assess the efficiency of the affinity purification, western blot
analysis was performed on cell lysates (INPUT) and on affinity-purified CH, RIG-I, or MDA5 (OUTPUT) with anti-STrEP tag antibodies. Similar results were
obtained in three independent experiments.
(G andH) Infectionswith (G) DENV-2 and (H) DENV-4were performed as in (F). Total RNAs (INPUT), RNAs extracted fromRLR/RNA complexes (OUTPUT), or 503P
RNA were transfected into STING-37 cells for 24 hr. Immuno-stimulatory activities of RNAs were assessed by luciferase assays. Data are presented as fold
stimulation of luciferase expression relative to un-stimulated control cells.
Data are means ±SD of three (C, D, E, G, and H) or four (A and B) independent experiments. Significance was calculated using a one-sample t test to a theoretical
mean of 100 (A, C, D, and E) or one-way ANOVA with a Tukey’s multiple comparison test (B, G, and H). For clarity, non-significant (ns) differences were not
depicted in (G and H). *p < 0.05; **p < 0.01; ***p < 0.001.
See also Figure S1.Kato et al., 2006; Pichlmair et al., 2009). Induction of IFNB or
ISG56mRNAs (Figures 2C and 2D) or ISRE activation (Figure 2E)
showed that STING-37 cells were stimulated by 503P, LMW
poly(I:C), and RNAs extracted from mengovirus-infected cells.
As expected (Kato et al., 2008), both levels of IFNB or ISG56
transcripts and ISRE activation were reduced by approximately
90% in sh-RIG-I cells stimulated by 503P RNAs or with LMW
poly(I:C), compared to control cells (Figures 2C–2E). The levels
of ISG56 or IFNB transcripts were also reduced in sh-MDA5
cells, compared to control cells, upon LMW poly(I:C) stimulation
(Figures 2C and 2D), which was expected (Kato et al., 2008). In
agreement with previous work (Feng et al., 2012; Gitlin et al.,
2006; Kato et al., 2006; Pichlmair et al., 2009), levels of IFNB tran-
scripts, as well as ISRE activation, were reduced by approxi-
mately 70% and 85%, respectively, in sh-MDA5 cells stimulated
by RNA extracted from mengovirus-infected cells, compared to
control cells (Figures 2C–2E). These data confirmed that the level
of RIG-I and MDA5 silencing was sufficient to affect the magni-322 Cell Reports 24, 320–328, July 10, 2018tude of the response they mediate. Following 24 hr of infection
with DENV-2 or DENV-4, IFNB and ISG56mRNAs were reduced
by 90% in cells in which RIG-I expression was reduced,
compared to control cells (Figures 2C and 2D). Consistently,
RIG-I silencing significantly diminished ISRE activation upon
DENV-2 or DENV-4 infection (Figure 2E). By contrast, diminished
expression of MDA5 had little to no effect on ISG56/IFNB tran-
script levels or ISRE activation upon infection by either DENV
serotypes (Figures 2C–2E). These results suggest that RIG-I is
the primary cytosolic sensor of DENV-2 and DENV-4 infections.
To test the immune activity of viral RNAs bound to RIG-I and
MDA5, we took advantage of HEK293 cell lines stably express-
ing One-STrEP-tagged RIG-I or MDA5 proteins (ST-RLR cells),
or as a control, One-STrEP-tagged Cherry (ST-CH cells) (San-
chez David et al., 2016). ST-RLR and ST-CH cells were infected
by DENV-2 or DENV-4 for 24 hr, and total RNAs (input RNA), as
well as RNAs that co-purified with RIG-I andMDA5 (output RNA),
were transfected into STING-37 cells for 24 hr. Western blot
Figure 3. RIG-I Recognizes the 50 Region of the DENV Genome
HEK293 ST-RLR cells were infected with DENV-2 Malaysia (A, C, E, G, I, and K) and DENV-4 Dominica (B, D, F, H, J, and L) at an FIU of 0.5.
(A andB) The relative amounts of cell-associated viral RNAwere determined by qPCR analysis at 15min, 8 hr, 24 hr, and 48 hr post-infection and are expressed as
GE per microgram of total cellular RNA. (A) DENV-2. (B) DENV-4.
(C and D) The presence of extracellular infectious DENV-2 (C) and DENV-4 (D) viruses in culture medium at 48 hr post-infection was determined by in-cell western
blot on Vero cells.
(E and F) Amounts of (left) IFNB and (right) ISG56 mRNAs were determined by real-time qPCR analysis at the indicated time post-DENV2 (E) and DENV-4 (F)
infection.
(G and H) Cell culture medium was analyzed by ELISA to determine the amounts of IFN-b secreted at 48 hr post-DENV-2 (G) and DENV-4 (H) infection.
(I and J) At 24 hr post-infection, total cell lysates were used for total RNA purification (INPUT RNA) and for affinity purification of RLR/RNA complexes, followed by
RNA extraction. (I) DENV-2. (J) DENV-4. INPUTRNA, RIG-I/RNA,MDA5/RNA, andCH/RNA sampleswere subjected to strand-specific NGS analysis. Sequencing
reads were mapped to DENV genomes after sample size normalization based on INPUT samples. Differential analyses were performed between RLR/RNA and
CH/RNA samples. The distribution of normalized read coveragematching DENV genomes is represented along the viral genome, with the x axis corresponding to
DENV genome nucleotides and the y axis showing the fold enrichment on beads between RIG-I (gray) or MDA5 (blue) compared to CH control. The smooth curves
were obtained from averaging read coverage of three independent experiments.
(K and L) Total RNA samples (INPUT) and RIG-I co-purified RNA (OUTPUT) were subjected to real-time qPCR analysis with specific primers at different positions
along the DENV genomes. (K) DENV-2. (L) DENV-4. Data are represented as fold enrichments relative to control CH samples.
(M) In-vitro-transcribed RNA fragments of250 bp corresponding to 50 and 30 regions of DENV-2 and DENV-4 genomes, or to Cherry or actin RNAs, were treated
or not with CIP and transfected into STING-37 cells. Cells transfected with LMW poly(I:C) or 503P RNA served as positive controls. Immuno-stimulatory activities
of those RNAs were assessed by luciferase assay 24 hr post-transfection. Data are presented as fold increase of luciferase expression relative to un-stimulated
cells transfected. EV, empty vector.
(legend continued on next page)
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analysis confirmed the efficiency of purification of RIG-I and
MDA5 proteins using our affinity chromatography approach (Fig-
ure 2F). STING-37 cells transfectedwith 503PRNAswere used as
a positive control. None of the input RNA was able to stimulate
ISRE (Figures 2G and 2H). This is probably because viral
RNAs, which represented around 0.1% of total RNAs in infected
cells (Table S1), were not concentrated enough in the input frac-
tion to be immune active. Alternatively, an inhibitor and/or a
competitor of IFN induction that co-purifiedwith input RNA could
explain the lack of response of this fraction. RNAs that co-puri-
fied with RIG-I in cells infected with DENV-2 or DENV-4 were im-
muno-stimulatory, while RNAs bound to MDA5 or Cherry were
not (Figures 2G and 2H). These data are in agreement with the
silencing experiments (Figures 2C–2E) and support a key role
for RIG-I in cellular response following 24 hr of DENV infection.
RIG-I Recognizes the 50 Region of the DENV Genome
Previous studies have demonstrated that both RIG-I and MDA5
are engaged in sensing flavivirus replication (Sprokholt et al.,
2017; Suthar et al., 2013). However, our data suggest a minor
role of MDA5 in stimulating an IFN response upon DENV infec-
tion. To clarify this question, we characterized viral RNAs asso-
ciated with both RIG-I and MDA5 during DENV-2 and DENV-4
infection using strand-specific NGS analysis. We first studied
DENV replication and induction of immune response in ST-RLR
and ST-CH cells. All cells were infected with the same volume
of viral inoculum, which corresponded to 50% of cells positive
for viral envelope (Env) at 24 hr. Real-time qPCR analysis re-
vealed that one-STrEP-tagged RIG-I (ST-RIG-I) cells produced
slightly less viral RNA than did control cells or one-STrEP-tagged
MDA5 (ST-MDA5) cells (Figures 3A and 3B). Such modest effect
of RIG-I overexpression on DENV replication was surprising in
light of our silencing and immuno-stimulatory data (Figure 2). It
may be explained by the ability of the virus to dampen type I
IFN induction (Ngono and Shresta, 2018; Suthar et al., 2013).
Indeed, in a system free of IFN antagonist, ST-RIG-I cells gener-
ated 100 times more IFNB mRNA and 5 times more ISG56
mRNA than did ST-CH control cells upon 8 hr of LMW poly(I:C)
stimulation (Figure S2). Assessment of viral titers at 48 hr post-
infection showed that DENV-2 and DENV-4 were efficiently
released from the 3 cell lines, indicating that they were
completing a full replication cycle (Figures 3C and 3D). Levels
of both IFNB and ISG56 transcripts increased from 24 hr post-
infection (Figures 3E and 3F). Upon 48 hr of infection, around
100 times more IFN-b was secreted in the 3 cell lines compared
to non-infected cells (Figures 3G and 3H). These data indicate
that both viruses induced an innate immune response in ST-
RLR and ST-CH cells. Based on these data, the NSG analyses
were performed at 24 hr post-infection. RNAs from total cell ex-
tracts were purified (input RNA), as well as RNAs bound to RIG-I,
MDA5, or Cherry (output RNA). The Illumina sequencing pro-
vided high output, in the order of 50 to 100million reads per sam-(A–H and M) Data are means ± SD of three independent experiments. Significanc
test. For clarity, non-significant (ns) differences were not depicted. (K and L) D
experiments. **p < 0.01; ***p < 0.001.
See also Figures S2 and S3 and Table S1.
324 Cell Reports 24, 320–328, July 10, 2018ple (Table S1), with an average length of 63 nt. Around 0.02% to
0.25% of these reads mapped on DENV-2 or DENV-4 genomes
(Table S1). The abundance of reads aligned on the DENV
genome that purified with the two RLRs was first normalized to
the abundance of reads aligned on the DENV genome in total
RNAs (‘‘normalized coverage’’). To discard RNAs sequences
that bind non-specifically to the beads, the normalized abun-
dance of reads aligned on viral RNAs bound to the two RLRs
was normalized to reads pulled down with the Cherry control.
The analysis revealed that no negative sense viral RNA was
associated with the two RLRs, demonstrating that viral dsRNA
replication intermediates generated during DENV infection are
not RLR ligands. No specific enrichment of viral RNAs was de-
tected on MDA5 during DENV-2 or DENV-4 infection (Figures
3I and 3J, blue lines). This suggests that DENV-2 and DENV-4
genomes are not recognized by MDA5 in HEK293 cells at 24 hr
post-infection, confirming the silencing and immuno-stimulatory
experiments. The profile of viral reads abundance associated
with RIG-I revealed an enrichment of the 50 region of the DENV
genomes on RIG-I (Figures 3I and 3J, gray lines). Specifically,
RNA mapping to the first 2,000 nt of DENV-2 and DENV-4
genome were 3 to 7 times more abundant on RIG-I than on
Cherry. This enrichment of viral reads on RIG-I gradually
decreased from around 2,000 nt toward the 30 region of both
DENV genomes (Figures 3I and 3J, gray lines).
Since the three NGS independent experiments showed some
variability in RIG-I enrichment (Figures 3I and 3J, gray lines), a
principal-component analysis (PCA) of individual samples was
performed to visualize trends across the three datasets (Fig-
ure S3). The PCA plots showed that the main source of variability
along dimension 1 corresponded to clustering of ST-RIG-I from
ST-CH and ST-MDA5 samples (Figure S3), confirming that,
upon DENV2 or DENV4 infection, RNAs bound to RIG-I were
markedly different from RNAs bound to Cherry and MDA5.
To validate the NGS data, primer pairs amplifying five regions
of the two DENV genomes were designed to perform real-time
qPCR analysis on RNAs purified from total cell extracts or from
RIG-I pull-down. The data were normalized to their respective
Cherry negative control. The50 regionofDENV-2 andDENV-4ge-
nomes was approximately 4 to 8 times more abundant on RIG-I
than on Cherry, depending on the biological replicates (Figures
3K and 3L). This variability is similar to the one observed during
the NGS experiments. The enrichment of DENV-2 and DENV-4
RNAonRIG-I compared toCherry decreasedgradually for the re-
gions that were further away from the 50 end of the genome and
was null for the region corresponding to nt 10,401–10,634, which
lies within the 30UTR (Figures 3K and 3L). Together, the NGS and
qPCR data suggest that RIG-I recognizes specifically the 50 re-
gion of DENV-2 and DENV-4 genomes.
To validate further the NGS data and narrow down the viral
region recognized by RIG-I, RNAs corresponding to the first
250 nt of the DENV-2 genome and the first 240 nt of thee was calculated using a one-way ANOVA with a Tukey’s multiple comparison
ata are means ± SD of technical triplicates representative of 2 independent
Figure 4. RIG-I Recognizes the 50 Region of the ZIKV Genome
HEK293 ST-RIG-I or ST-CH cells were infected with ZIKV HD78788 at an FIU of 0.5.
(A) The relative amounts of cell-associated viral RNA were determined by qPCR analysis at 15 min, 8 hr, 24 hr, or 48 hr post-infection. Amounts of viral RNA are
expressed as genome equivalents (GEs) per microgram of total cellular RNA.
(B) The presence of extracellular infectious viruses released in culture medium at 48 h post-infection was determined by plaque assays on Vero cells.
(C) Amounts of IFNB and ISG56 mRNA were determined by real-time qPCR analysis at 8, 24, and 48 hr post-infection.
(D) Cell-culture medium was analyzed by ELISA to determine the amounts of IFN-b secreted at 48 hr post-infection.
(E) HEK293 ST-RIG-I or ST-CH cells were infected for 24 hr. Western blot analysis was performed on cell lysates (INPUT) and on affinity-purified RIG-I (OUTPUT)
with anti-STrEP tag antibodies. Similar results were obtained in three independent experiments.
(F) Immuno-stimulatory activities of RNAswere assessed by transfecting INPUT or OUTPUTRNAs into ISRE reporter cells. Transfectionwith 503PRNAs served as
positive control. Data are presented as fold stimulation of luciferase expression relative to un-stimulated control cells (mock).
(G) Total RNA samples (INPUT) and RIG-I co-purified RNA (OUTPUT) were subjected to real-time qPCR analysis, with specific primers at different positions along
the ZIKV genomes. Data are represented as fold enrichments relative to control CH samples.
Data are means ± SD of two (A–D) or three (F) independent experiments. In (G), data are means ± SD of technical triplicates representative of 2 independent
experiments. In (F), significance was calculated using a one-way ANOVA with a Tukey’s multiple comparison test. ***p < 0.001. For clarity, non-significant (ns)
differences were not depicted.DENV-4 genome, as well as RNAs corresponding to the last
250 nt at the 30 end of both genomes, were synthesized in vitro
and transfected into STING-37 cells. In-vitro-synthesized RNAs
corresponding to a 250-nt portion of actin and Cherry mRNA
were used as controls. 503P groups were removed, or not,
from in-vitro-synthesized RNAs by calf intestine alkaline phos-
phatase (CIP) treatment. 503P and LMW poly(I:C) served as pos-
itive controls, and, as expected, they both stimulated ISRE (Fig-
ure 3M). Transcripts corresponding to the first 250 nt of DENV-2
and first 240 nt of DENV-4 were immuno-stimulatory, whereas
transcripts corresponding to the 30 end were not (Figure 3M).
This was in good agreement with NGS data (Figures 3I and 3J)
and real-time qPCR experiments (Figures 3K and 3L). CIP treat-
ment resulted in complete loss of immuno-stimulatory activity of
the 50 end of DENV genomes (Figure 3M), confirming that viral
RIG-I ligands contain a 3P group (Hornung et al., 2006).
RIG-I Recognizes the 50 Region of the ZIKV Genome
To investigate whether RIG-I recognizes the genomic 50 end
of another flavivirus, we looked into the interaction between
RIG-I and RNAs produced during ZIKV infection. ST-RIG-I and
ST-CH cells were permissive to ZIKV replication (Figures 4Aand 4B). The levels of IFNB and ISG56 mRNAs at 24 and 48 hr
post-infection, as well as the secretion of IFN-b, revealed that
ZIKV infection induced an innate immune response in both cell
lines (Figures 4C and 4D). RNAs from total cell extracts and
RNAs that co-purified with RIG-I were collected (input and
output RNA, respectively) at 24 hr post-infection. As previously
(Figure 2F), western blot analysis confirmed the efficiency of
purification of RIG-I protein in the ‘‘output’’ fraction compared
to the ‘‘input’’ (Figure 4E). Input and output RNAs, as well as
503P, were transfected into STING-37 cells for 24 hr. As
observed earlier in the context of DENV infection (Figures 2G
and 2H), RNAs were not stimulating ISRE when non-concen-
trated on RIG-I (Figure 4F). On the contrary, RNAs that co-puri-
fied with RIG-I in cells infected with ZIKV were immuno-stimula-
tory (Figure 4F), revealing a key role for RIG-I in innate response
against ZIKV in human cells. Real-time qPCR analysis was per-
formed on input and output RNAs using primers amplifying five
regions of the ZIKV genome. Similar to DENV, the 50UTR region
of the ZIKV genome was the most enriched on RIG-I compared
to the 4 other regions (Figure 4G). The enrichment of viral RNA
on RIG-I decreased gradually along the genome toward the
30UTR (Figure 4G). This real-time qPCR profile resembled theCell Reports 24, 320–328, July 10, 2018 325
one obtained in the context of DENV infection (Figures 3K and
3L) and suggests that RIG-I recognizes the 50 end of the ZIKV
genome.
DISCUSSION
Using a panel of approaches, we confirmed the role of RIG-I in
sensing DENV in human cells. These results are in agreement
with studies performed with hepatoma Huh7 cells (Nasirudeen
et al., 2011), lung carcinoma A549 cells (Chang et al., 2006), hu-
man brain microvascular endothelial cells (da Conceic¸~ao et al.,
2013), and MDDCs (Sprokholt et al., 2017). They also reveal an
important role for RIG-I in innate response against ZIKV. Previ-
ous results obtained in mice embryo fibroblasts infected with
DENV-2 showed that both RIG-I and MDA5 are essential for
innate immune response (Loo et al., 2008), while our study shows
that MDA5 is not a DENV RNA sensor. Our work is in agreement
with data showing that IFN-b production was not affected by
MDA5 overexpression in Huh7 cells infectedwith DENV-1 (Nasir-
udeen et al., 2011). In MDDCs infected with DENV-2, the reduc-
tion of RIG-I expression had a more pronounced effect on IFN-b
expression than MDA5 reduction (Sprokholt et al., 2017), also
suggesting that RIG-I might play a more important role than
MDA5 in mediating the IFN-mediated antiviral response in these
physiologically relevant cells. One can envisage that MDA5
involvement in DENV sensing is species specific and different
between human and mouse cells. Alternatively, sensing of
DENV RNA by MDA5 may occur later than 24 hr post-infection.
Such distinct temporal activity of RIG-I and MDA5 during WNV
infection has been reported in mice (Errett et al., 2013).
The ability of the virus to counteract RLR signaling probably
masks the effect of RIG-I overexpression on DENV replication.
DENV have evolved multiple mechanisms to dampen IFN induc-
tion (Ngono and Shresta, 2018; Suthar et al., 2013). In particular,
DENV NS2A, NS4A, NS4B, NS2B3, and the viral subgenomic
RNA are targeting distinct steps of the RIG-I/MDA5 signaling to
reduce type I IFN production upon infection. This could explain
the modest effect of RIG-I overexpression on DENV replication
in our cellular system.
Several hypothetical flavivirus RIG-I ligands have been pro-
posed (Kell and Gale, 2015; Suthar et al., 2013), such as dsRNA
viral replicative intermediates formed by (+) and () strand asso-
ciation, the cyclization structure generated by interactions
between the 50 and 30 UTRs, and genomic RNA degradation
products. Our strand-specific NGS analysis invalidated theses
hypotheses and revealed that RIG-I binds the 50 end of 503P
nascent transcripts produced during flavivirus replication (Fig-
ure S4). Indeed, during replication, multiple growing nascent
(+) strand RNAs are synthesized on one () strand template at
a time (Klema et al., 2015). Initiation of a new transcript implies
the displacement of 50 end of the nearest pre-existing growing
transcript from the template. Such mechanism produces a chain
of growing nascent transcripts of gradual sizes, which explains
our NGS profiles. The interaction between RIG-I and the 50 end
of the flaviviral genomes must occur before capping, the first
step of which consists of releasing the terminal phosphate
from the 503P end of the (+) strand by the viral NS3 protein (Klema
et al., 2015).326 Cell Reports 24, 320–328, July 10, 2018Several high-resolution crystal structures of RIG-I:dsRNA
co-crystals (Kolakofsky et al., 2012) have revealed that the
CTD domain of RIG-I binds blunt-ended base-paired 503P
RNA. These studies also revealed that RIG-I, when bound to
dsRNA, exhibits a disk-shaped central cavity that accommo-
dates around 9 bp of RNA. The flavivirus 50UTR contains a
conserved, 70-nt-long, Y-shaped stem-loop structure, called
stem-loop A (SLA), which acts as a viral promoter (Villordo
et al., 2016). We propose that the double-stranded stem of
this SLA, which is located 3 nt away from the 503P (Lodeiro
et al., 2009), is a potent RIG-I agonist. Such recognition by
RIG-I of one the most conserved elements within the flavivirus
genome would offer limited viral adaptation for immune
evasion.
EXPERIMENTAL PROCEDURES
Affinity Chromatography of RLR-RNP Complexes and Subsequent
RNA and Protein Purification
ST-RLR and ST-CH cells (5 3 107) were infected with DENV or ZIKV at a fluo-
rescent infectivity unit (FIU) of 0.5 for 24 hr. Cells were washed twice with cold
PBS and lysed in 6 mL of lysis buffer (20 mM MOPS-KOH [pH 7.4], 120 mM
KCl, 0.5% Igepal, 2 mM b-mercaptoethanol), supplemented with 200 U/mL
RNasin (Promega) and Complete Protease Inhibitor Cocktail (Roche). Cell ly-
sates were incubated on ice for 20 min, with gentle mixing every 5 min, and
then clarified by centrifugation at 16,0003 g for 15min at 4C. A 250-mL aliquot
of each cell lysate was used to perform total RNA purification using TRI
Reagent LS [Sigma]). The remaining cell lysate was incubated for 2 hr on a
spinning wheel at 4C with 200 mL StrepTactin Sepharose High Performance
beads (GE Healthcare). Beads were collected by centrifugation (1,600 3 g
for 5 min at 4C) and washed twice for 5 min on a spinning wheel with 5 mL
washing buffer (20mMMOPS-KOH [pH 7.4], 120mMKCl, 2mM b-mercaptoe-
thanol) supplemented with 200 U/mL RNasin and complete protease inhibitor
cocktail. Precipitates were eluted using biotin elution buffer (IBA Lifesciences).
RNA purification was performed using TRI Reagent LS (T3934; Sigma). RNA
was dissolved in 50 mL DNase-free and RNase-free ultrapure water. Extracted
RNAs were analyzed using Nanovue (GE Healthcare) and the Bioanalyser RNA
nano kit (Agilent Technologies).
NGS
RNA molecules isolated from ST-RLR/RNA complexes from three indepen-
dent experiments were treated for library preparation using the TruSeq
Stranded mRNA Sample Preparation Kit (Illumina) according to the manufac-
turer’s instructions. To analyze all RNA species present, the initial poly(A)
RNA isolation step was omitted. Briefly, the fragmented RNA samples were
randomly primed for reverse transcription followed by second-strand synthe-
sis to create double-stranded cDNA fragments. No end repair step was neces-
sary. An adenine was added to the 30 end, and specific Illumina adapters were
ligated. Ligation products were submitted to PCR amplification. Sequencing
was performed on the Illumina Hiseq 2000 platform to generate single-end
65-bp reads bearing strand specificity.
Analysis of RLR/RNA Enrichment Profiles by Real-Time qPCR
RNA was extracted with TRI Reagent LS before or after affinity chromatog-
raphy purification on StrepTactin Sepharose beads. cDNA synthesis was
achieved using the SuperScript VILO cDNA Synthesis Kit (Life Technologies),
following manufacturer’s recommendations. Real-time qPCR was performed
using a real-time PCR system (QuantStudio 6 Flex, Applied Biosystems) with
SYBR Green PCR Master Mix (Life Technologies) using DENV and ZIKV
primers at different positions along the viral genome (Table S2). RNA fold
enrichment (FE) and normalized fold enrichment (NFE) were calculated
according to the following formulas:
FEðCtÞ = 2
½ðCtqueryCtGAPDHÞOUTPUTðCtqueryCtGAPDHÞINPUT and
NFEðprimerÞ =
RLR:FEðprimerÞ
mCherry:FEðprimerÞ
:
Statistical Analysis
Graphical representation and statistical analyses were performed using
Prism5 software (GraphPad Software). Unless otherwise stated, results are
shown as means ± SD from 3 independent experiments. Significance was
calculated using Student’s t test for pairwise comparisons or one-way
ANOVA with a Tukey’s multiple comparison test when comparing more than
two sets of values. Statistically significant differences are indicated as follows:
*p < 0.05; **p < 0.01; ***p < 0.001; and ns, not significant.
SUPPLEMENTAL INFORMATION
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